Related Experiment Video
Updated: Jan 13, 2026

17:14
Compact Quantum Dots for Single-molecule Imaging
Published on: October 9, 2012
18.6K
Carbonized Polymer Dots as Versatile Nanocarrier for Bioincompatible Fluorophore Imaging.
Feishi Shan1,2, Lijuan Fu1, Chengshuang Liao1
1Sichuan Engineering Research Center for Molecular Targeted Diagnostic & Therapeutic Drugs, Department of Chemistry, Xihua University, Chengdu, 610039, China.
Angewandte Chemie (International Ed. in English)
|January 10, 2026
Summary
Carbonized polymer dots (CPDs) offer a novel solution to deliver impermeable fluorophores into cells. This breakthrough enables enhanced intracellular fluorescence bioimaging and theranostics.
Area of Science:
- Materials Science
- Biotechnology
- Nanotechnology
Background:
- Cell permeability is a major limitation for many high-performance fluorophores in bioimaging.
- Existing fluorescence probes often struggle to cross cell membranes effectively, hindering their application.
Purpose of the Study:
- To develop a versatile platform for delivering impermeable fluorophores into cells.
- To overcome the cell permeability barrier for enhanced fluorescence bioimaging and theranostics.
Main Methods:
- Development of carbonized polymer dots (CPDs-280) as a noncovalent translocation platform.
- Formation of stable nanocomplexes with impermeable fluorophores, including HECA, ESY-Na+, and ESY.
- Demonstration of carrier-dominated intracellular localization and cargo-agnostic delivery.
Main Results:
- CPDs-280 successfully complexed with and delivered various impermeable fluorophores into the cytosol.
- The platform demonstrated a high loading capacity (∼50.8%) and overrode innate targeting signals of dyes.
- Intracellular luminescence was achieved with previously inert membrane-impermeable amphiphilic dyes upon complexation.
Conclusions:
- Carbonized polymer dots provide a generic, noncovalent strategy to enhance fluorophore cell permeability.
- This approach unlocks a vast range of underutilized fluorescent probes for advanced bioimaging.
- The CPD platform holds significant potential for future theranostic applications.

